Sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM in 45 mL Oral Solution
RxNorm 1604338
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1604338 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM in 45 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Sodium phosphate, dibasic 60 mg/ML / sodium phosphate, monobasic 160 mg/ML Oral Solution
(Atom ID: 12349484)
PSN
Prescribable Name (PSN):
Sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM in 45 mL Oral Solution
(Atom ID: 13050169)
SY
Synonym (SY):
Sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 45 mL Oral Solution
(Atom ID: 6833608)
Patient Education
Sodium Phosphate
Sodium phosphate is used in adults 18 years of age or older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium phosphate is in a class of medications called saline laxatives. It works by causing diarrhea so that the stool can be emptied from the colon.
[Learn More]
* Please review the disclaimer below.